Precision Dosing Priority Criteria: Drug, Disease, and Patient Population Variables
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Precision Dosing Priority Criteria: Drug, Disease, and Patient Population Variables
Authors
Keywords
-
Journal
Frontiers in Pharmacology
Volume 11, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2020-04-22
DOI
10.3389/fphar.2020.00420
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- What Does it Take to Make Model-Informed Precision Dosing Common Practice? Report from the 1st Asian Symposium on Precision Dosing
- (2019) Thomas M. Polasek et al. AAPS Journal
- The New Paradigms in Clinical Research: From Early Access Programs to the Novel Therapeutic Approaches for Unmet Medical Needs
- (2019) Cristina Scavone et al. Frontiers in Pharmacology
- Nimotuzumab and radiotherapy for treatment of newly diagnosed diffuse intrinsic pontine glioma (DIPG): a phase III clinical study
- (2019) G. Fleischhack et al. JOURNAL OF NEURO-ONCOLOGY
- Handling interoccasion variability in model-based dose individualization using therapeutic drug monitoring data
- (2019) João A. Abrantes et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Reduction in Nephrotoxic Antimicrobial Exposure Decreases Associated Acute Kidney Injury in Pediatric Hematopoietic Stem Cell Transplant Patients
- (2019) Stefanie W. Benoit et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- Optimizing the dose in patients treated with imatinib as first line treatment for gastrointestinal stromal tumors: A cost‐effectiveness study
- (2019) Ingrid M.E. Desar et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Infectious Disease Hospitalizations
- (2019) Jordan L. Kennedy et al. CHEST
- Lowering Cost and Increasing Access to Drugs Without Jeopardizing Innovation
- (2019) Robert M. Califf et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Individualized dosing of oral targeted therapies in oncology is crucial in the era of precision medicine
- (2019) Stefanie L. Groenland et al. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
- Impact of low tacrolimus exposure and high tacrolimus intra-patient variability on the development of de novo anti-HLA donor-specific antibodies in kidney transplant recipients
- (2019) Aleixandra Mendoza Rojas et al. Expert Review of Clinical Immunology
- High tacrolimus trough level variability is associated with rejections after heart transplantation
- (2018) Itai Gueta et al. AMERICAN JOURNAL OF TRANSPLANTATION
- Cost of Prescription Drug–Related Morbidity and Mortality
- (2018) Jonathan H. Watanabe et al. ANNALS OF PHARMACOTHERAPY
- Adaptive designs in clinical trials: why use them, and how to run and report them
- (2018) Philip Pallmann et al. BMC Medicine
- Biomarker definitions and their applications
- (2018) Robert M Califf EXPERIMENTAL BIOLOGY AND MEDICINE
- Obesity and drug pharmacology: a review of the influence of obesity on pharmacokinetic and pharmacodynamic parameters
- (2018) Cornelis Smit et al. Expert Opinion on Drug Metabolism & Toxicology
- Improvement in clinical outcomes and replacement factor VIII use in patients with haemophilia A after factor VIII pharmacokinetic-guided prophylaxis based on Bayesian models with myPKFiT®
- (2018) M. E. Mingot-Castellano et al. HAEMOPHILIA
- Improving Public Health Requires Inclusion of Underrepresented Populations in Research
- (2018) Catherine Y. Spong et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Therapeutic Drug Monitoring is More Cost-Effective than a Clinically Based Approach in the Management of Loss of Response to Infliximab in Inflammatory Bowel Disease: An Observational Multicentre Study
- (2018) Luisa Guidi et al. Journal of Crohns & Colitis
- Biomarkers as drug development tools: discovery, validation, qualification and use
- (2018) Virginia B. Kraus Nature Reviews Rheumatology
- Precision dosing in clinical medicine: present and future
- (2018) Thomas M. Polasek et al. Expert Review of Clinical Pharmacology
- Improvement of Adequate Digoxin Dosage: An Application of Machine Learning Approach
- (2018) Ya-Han Hu et al. Journal of Healthcare Engineering
- Definition and Validation of a Novel Metric of Erythropoiesis-Stimulating Agent Response in Hemodialysis Patients
- (2018) Calvin J. Meaney et al. JOURNAL OF CLINICAL PHARMACOLOGY
- Determining the Balance Between Drug Efficacy and Safety by the Network and Biological System Profile of Its Therapeutic Target
- (2018) Xiao xu Li et al. Frontiers in Pharmacology
- Value-Based Pricing and State Reform of Prescription Drug Costs
- (2017) Thomas J. Hwang et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Global, Regional, and National Burden of Cardiovascular Diseases for 10 Causes, 1990 to 2015
- (2017) Gregory A. Roth et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- A Phamacoeconomic Analysis of Personalized Dosing vs Fixed Dosing of Pembrolizumab in Firstline PD-L1-Positive Non–Small Cell Lung Cancer
- (2017) Daniel A Goldstein et al. JNCI-Journal of the National Cancer Institute
- Deficiencies in Traditional Oral Dosage Forms and the Emergence of Controlled-Release Powder Manufacturing
- (2017) Martin G. Teresk et al. KONA Powder and Particle Journal
- A Systematic Literature Review Approach to Estimate the Therapeutic Index of Selected Immunosuppressant Drugs After Renal Transplantation
- (2017) Jessica E. Ericson et al. THERAPEUTIC DRUG MONITORING
- Aging Gut Microbiota at the Cross-Road between Nutrition, Physical Frailty, and Sarcopenia: Is There a Gut–Muscle Axis?
- (2017) Andrea Ticinesi et al. Nutrients
- A Phamacoeconomic Analysis of Personalized Dosing vs Fixed Dosing of Pembrolizumab in Firstline PD-L1-Positive Non–Small Cell Lung Cancer
- (2017) Daniel A Goldstein et al. JNCI-Journal of the National Cancer Institute
- Addressing the challenge of high-priced prescription drugs in the era of precision medicine: A systematic review of drug life cycles, therapeutic drug markets and regulatory frameworks
- (2017) Toon van der Gronde et al. PLoS One
- Open-label, randomized study of individualized, pharmacokinetically (PK)-guided dosing of paclitaxel combined with carboplatin or cisplatin in patients with advanced non-small-cell lung cancer (NSCLC)
- (2016) M. Joerger et al. ANNALS OF ONCOLOGY
- Therapeutic Index Estimation of Antiepileptic Drugs
- (2016) Rachel G. Greenberg et al. CLINICAL NEUROPHARMACOLOGY
- The use of pharmacokinetics in dose individualization of factor VIII in the treatment of hemophilia A
- (2016) Alanna McEneny-King et al. Expert Opinion on Drug Metabolism & Toxicology
- Biomarkers and Surrogate Endpoints
- (2016) Melissa A. Robb et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Multivariate analysis of the population representativeness of related clinical studies
- (2016) Zhe He et al. JOURNAL OF BIOMEDICAL INFORMATICS
- Cost-effectiveness of drug monitoring of anti-TNF therapy in inflammatory bowel disease and rheumatoid arthritis: a systematic review
- (2016) Laura Martelli et al. JOURNAL OF GASTROENTEROLOGY
- Awareness, Understanding, and Adoption of Precision Medicine to Deliver Personalized Treatment for Patients With Cancer: A Multinational Survey Comparison of Physicians and Patients
- (2016) Fortunato Ciardiello et al. ONCOLOGIST
- Use of Therapeutic Drug Monitoring, Electronic Health Record Data, and Pharmacokinetic Modeling to Determine the Therapeutic Index of Phenytoin and Lamotrigine
- (2016) Lawrence C. Ku et al. THERAPEUTIC DRUG MONITORING
- Overspending driven by oversized single dose vials of cancer drugs
- (2016) Peter B Bach et al. BMJ-British Medical Journal
- Overspending driven by oversized single dose vials of cancer drugs
- (2016) Peter B Bach et al. BMJ-British Medical Journal
- Rapid Test for Infliximab Drug Concentration Allows Immediate Dose Adaptation
- (2016) Thomas Van Stappen et al. Clinical and Translational Gastroenterology
- Relationship between cytochrome P450 polymorphisms and prescribed medication in elderly haemodialysis patients
- (2016) Krystina Parker et al. SpringerPlus
- Meta-Analysis to Assess the Quality of Warfarin Control in Atrial Fibrillation Patients in the United States
- (2016) William L. Baker et al. JOURNAL OF MANAGED CARE PHARMACY
- A Bioequivalence Approach for Generic Narrow Therapeutic Index Drugs: Evaluation of the Reference-Scaled Approach and Variability Comparison Criterion
- (2015) Wenlei Jiang et al. AAPS Journal
- Pharmacokinetics and Toxicity of Tacrolimus Early After Heart and Lung Transplantation
- (2015) M. A. Sikma et al. AMERICAN JOURNAL OF TRANSPLANTATION
- Why therapeutic drug monitoring is needed for monoclonal antibodies and how do we implement this?
- (2015) DR Mould CLINICAL PHARMACOLOGY & THERAPEUTICS
- Narrow therapeutic index drugs: a clinical pharmacological consideration to flecainide
- (2015) Juan Tamargo et al. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
- Trough Concentrations of Infliximab Guide Dosing for Patients With Inflammatory Bowel Disease
- (2015) Niels Vande Casteele et al. GASTROENTEROLOGY
- Double-Blind Phase III Randomized Trial of the Antiprogestin Agent Mifepristone in the Treatment of Unresectable Meningioma: SWOG S9005
- (2015) Yongli Ji et al. JOURNAL OF CLINICAL ONCOLOGY
- ACC/AHA/STS Statement on the Future of Registries and the Performance Measurement Enterprise
- (2015) Deepak L. Bhatt et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- A New Initiative on Precision Medicine
- (2015) Francis S. Collins et al. NEW ENGLAND JOURNAL OF MEDICINE
- Revision of omalizumab dosing table for dosing every 4 instead of 2 weeks for specific ranges of bodyweight and baseline IgE
- (2015) Philip J. Lowe et al. REGULATORY TOXICOLOGY AND PHARMACOLOGY
- Bacteriostatic versus bactericidal antibiotics for patients with serious bacterial infections: systematic review and meta-analysis
- (2014) Johannes Nemeth et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- A Distribution-based Method for Assessing The Differences between Clinical Trial Target Populations and Patient Populations in Electronic Health Records
- (2014) P. Ryan et al. Applied Clinical Informatics
- Pharmacokinetic-Pharmacodynamic Modelling of Biomarker Response to Sitagliptin in Healthy Volunteers
- (2013) Bo-Hyung Kim et al. BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY
- Individualised therapy is more cost-effective than dose intensification in patients with Crohn’s disease who lose response to anti-TNF treatment: a randomised, controlled trial
- (2013) Casper Steenholdt et al. GUT
- Analyses of marketplace tacrolimus drug product quality: Bioactivity, NMR and LC–MS
- (2013) Cynthia D. Sommers et al. JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS
- Pharmacogenomics in early-phase clinical development
- (2013) Tal Burt et al. PHARMACOGENOMICS
- Cytochrome P450 enzymes in drug metabolism: Regulation of gene expression, enzyme activities, and impact of genetic variation
- (2013) Ulrich M. Zanger et al. PHARMACOLOGY & THERAPEUTICS
- Potential Cost-effectiveness of Therapeutic Drug Monitoring for Depressed Patients Treated With Citalopram
- (2013) Elnaz Ostad Haji et al. THERAPEUTIC DRUG MONITORING
- Drug Labeling and Exposure in Neonates
- (2013) Matthew M. Laughon et al. JAMA Pediatrics
- Pitfalls and limitations in translation from biomarker discovery to clinical utility in predictive and personalised medicine
- (2013) Elisabeth Drucker et al. EPMA Journal
- Meta-Analysis of Cytochrome P450 2C19 Polymorphism and Risk of Adverse Clinical Outcomes Among Coronary Artery Disease Patients of Different Ethnic Groups Treated With Clopidogrel
- (2012) Jae-Sik Jang et al. AMERICAN JOURNAL OF CARDIOLOGY
- Clinical Outcomes Associated with Brand-to-Generic Phenytoin Interchange
- (2012) Shilpa A Kinikar et al. ANNALS OF PHARMACOTHERAPY
- Is Peak Concentration Needed in Therapeutic Drug Monitoring of Vancomycin? A Pharmacokinetic-Pharmacodynamic Analysis in Patients with Methicillin-ResistantStaphylococcus aureusPneumonia
- (2012) Yosuke Suzuki et al. CHEMOTHERAPY
- Evidence-Based Management of Anticoagulant Therapy
- (2012) Anne Holbrook et al. CHEST
- Individualization of Drug Therapy: History, Present State, and Opportunities for the Future
- (2012) L J Lesko et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Generic and Brand-Namel-Thyroxine Are Not Bioequivalent for Children With Severe Congenital Hypothyroidism
- (2012) Jeremi M. Carswell et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- The determination and interpretation of the therapeutic index in drug development
- (2012) Patrick Y. Muller et al. NATURE REVIEWS DRUG DISCOVERY
- Mechanism-Based Approach to the Economic Evaluation of Pharmaceuticals
- (2012) Joshua Pink et al. PHARMACOECONOMICS
- Safe and Effective Variability—A Criterion for Dose Individualization
- (2012) Nicholas H.G. Holford et al. THERAPEUTIC DRUG MONITORING
- Therapeutic drug monitoring of antimicrobials
- (2011) Jason A. Roberts et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Bring on the biomarkers
- (2011) George Poste NATURE
- Brand Name versus Generic Warfarin: A Systematic Review of the Literature
- (2011) Francesco Dentali et al. PHARMACOTHERAPY
- A Pharmacometric Model Describing the Relationship Between Warfarin Dose and INR Response With Respect to Variations in CYP2C9, VKORC1, and Age
- (2010) A-K Hamberg et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Limited blood sampling for pharmacokinetic dose tailoring of FVIII in the prophylactic treatment of haemophilia A
- (2010) S. BJÖRKMAN HAEMOPHILIA
- Infectious Disease Hospitalizations in the United States
- (2009) Krista L. Yorita Christensen et al. CLINICAL INFECTIOUS DISEASES
- Evaluation of population pharmacokinetic models for amikacin dosage individualization in critically ill patients
- (2009) María del Mar Fernández de Gatta et al. JOURNAL OF PHARMACY AND PHARMACOLOGY
- Overview of Therapeutic Drug Monitoring
- (2009) Ju-Seop Kang et al. KOREAN JOURNAL OF INTERNAL MEDICINE
- The Effect of CYP2C19 Polymorphism on the Pharmacokinetics and Pharmacodynamics of Clopidogrel: A Possible Mechanism for Clopidogrel Resistance
- (2008) KA Kim et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Individual Fluorouracil Dose Adjustment Based on Pharmacokinetic Follow-Up Compared With Conventional Dosage: Results of a Multicenter Randomized Trial of Patients With Metastatic Colorectal Cancer
- (2008) Erick Gamelin et al. JOURNAL OF CLINICAL ONCOLOGY
- Warfarin treatment in patients with atrial fibrillation: Observing outcomes associated with varying levels of INR control
- (2008) Christopher Ll. Morgan et al. THROMBOSIS RESEARCH
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now